|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1993-12-22
|
|
pubmed:abstractText |
We report a patient with severe psoriatic arthritis in whom the severity of both the arthritis and psoriasis fluctuated with the menstrual cycle. These features failed to improve with standard therapy, but there was a prompt response to treatment which suppressed oestrogen secretion. Such treatment should be considered in patients with disabling cyclical changes in psoriatic arthritis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0007-0963
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
129
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
458-60
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:8217763-Adult,
pubmed-meshheading:8217763-Arthritis, Psoriatic,
pubmed-meshheading:8217763-Buserelin,
pubmed-meshheading:8217763-Endometrium,
pubmed-meshheading:8217763-Estradiol,
pubmed-meshheading:8217763-Estrogen Antagonists,
pubmed-meshheading:8217763-Estrogens, Conjugated (USP),
pubmed-meshheading:8217763-Female,
pubmed-meshheading:8217763-Follicle Stimulating Hormone,
pubmed-meshheading:8217763-Goserelin,
pubmed-meshheading:8217763-Humans,
pubmed-meshheading:8217763-Luteinizing Hormone,
pubmed-meshheading:8217763-Menstruation,
pubmed-meshheading:8217763-Psoriasis,
pubmed-meshheading:8217763-Tamoxifen
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
Cyclical psoriatic arthritis responding to anti-oestrogen therapy.
|
|
pubmed:affiliation |
Department of Dermatology and Rheumatology, Royal Free Hospital and School of Medicine, London, U.K.
|
|
pubmed:publicationType |
Journal Article,
Case Reports
|
